Publications

Swartz, TH, Esposito, AM, Durham, ND, Hartmann, BM, and BK Chen. 2014. P2X-selective purinergic antagonists are strong inhibitors of HIV-1 fusion during both cell-to-cell and cell-free infection. J. Virol. http://doi.org/10.1128/JVI.01158-14. PMC4178786.

Yu, J, Wilkins, J, Ding, S, Swartz, TH, et al. 2015. IFITM Proteins Restrict HIV-1 Infection by Antagonizing the Envelope Glycoprotein. Cell Rep. 13(1):145-56. http://doi.org/10.1016/j.celrep.2015.08.055. PMC4602366

Esposito, A, Swartz, TH, and BK Chen. 2016. A high throughput cre-lox activated HIV membrane fusion assay identifies pharmacological inhibitors of viral entry. Virology. 490:6-16.http://doi.org/10.1016/j.virol.2015.10.013. PMC5019951.

Liu Y, Gaisa M, Wang X, Swartz TH, Arens Y, Dresser K, Sigel C, Sigel K. 2018. Immune Microenvironments of Anal Cancer Precursors Differ by HIV-serostatus, Affecting Ablation Outcomes. Journal of Infectious Diseases. J Infect Dis. Feb 14;217(5):703-709. http://doi.org/10.1093/infdis/jix454. PMC5853940.

Esposito, AM, Soare, AY, Patel, F, Satija, F, Chen, BK, and TH Swartz. 2018. A high throughput Cre-lox activated viral membrane fusion assay to identify inhibitors of HIV-1 viral membrane fusion. Journal of Visualized Experimentation. J Vis Exp. 183, e58074, http://doi.org/10.3791/58074. PMC6126790.

Liu, STH, Bailey, M, Zhen, A, Saunders-Hao, P, Bassily-Marcus, A, Harding, M, Rana, M, Kohli-Seth, R, Patel, G, Huprikar, S, and TH Swartz. 2018. An electronic antimicrobial stewardship intervention reduces inappropriate parenteral antibiotic therapy. Infection control and hospital epidemiology 39(11), p. 1396-1397. http://doi.org/10.1017/ice.2018.220.

Soare, AY, Durham, ND, Patel, F, Satija, N, Gopal, R, Tweel, B, Hoffman, KW, Upadhyay, C, O’Brien, M, Bhardwaj, N, Lim, JK, Hioe, CE, Chen, BK, and TH Swartz. 2019. P2X antagonists inhibit HIV-1 productive infection and inflammatory cytokines IL-10 and IL-1β in a human tonsil explant model. J Virol. e01186-18. http://doi.org/10.1128/JVI.01186-18. PMC6288349.

Arens, Y, Gaisa, M, Goldstone, S, Liu, Y, Wisnivesky, J, Sigel, C, Swartz, TH, Sigel, K. 2019. Risk of invasive anal cancer in HIV-1 infected patients with high-grade anal dysplasia: a population-based cohort study. Dis Colon Rectum. http://doi.org/10.1097/dcr.0000000000001384. PMC6613994.

Swartz, TH, Taylor-Starobin, B, Chen, BK, and Baron, MH. 2019. Twelve tips for facilitating the transition between PhD years and MD years in MD/PhD training. Med Ed Teach. June; 8(2):17. https://doi.org/10.15694/mep.2019.000087.1.

Swartz, TH, Palermo, AG, Masur, SK, and JA Aberg. The Science and Value of Diversity: Closing the Gaps in our Understanding of Inclusion and Diversity. 2019. J Infect Dis. Sep; 220 (2): S33–S41. http://doi.org/10.1093/infdis/jiz174. PMC6701939.

Soare, AY, Malik, HS, Durham, ND, Freeman, TL, Alvarez, RA, Patel, F, Satija, N, Upadhyay, C, Hioe, CE, Chen, BK, and TH Swartz. 2020. P2X1 selective antagonists block HIV-1 productive infection through inhibition of envelope-dependent fusion. J Virol; 94, 6. http://doi.org/10.1128/JVI.01622-19.

Freeman, TL and TH Swartz. 2020. Purinergic Receptors: Elucidating the Role of These Immune Mediators in HIV-1 Fusion. Viruses; 12, 290. https://doi.org/10.3390/v12030290.